BACKGROUND: Activity and chronicity of kidney involvement in ANCA-associated vasculitis (AAV) can be currently reliably evaluated only by kidney biopsy. In this study, we measured a panel of serum and urinary biomarkers collected at the time of kidney biopsy and hypothesized that they could reflect specific histopathological parameters in the biopsy and help to predict prognosis. METHODS: We examined a cohort of 45 patients with AAV and 10 healthy controls. Biomarker levels (DKK-3, CD163, EGF, PRO-C6 and C3M) were measured in this study by ELISA. Biopsies were scored with a scoring system for AAV (focal x crescentic x sclerotic x mixed class) and interstitial fibrosis was quantified. RESULTS: Levels of urinary DKK-3, CD163, EGF, PRO-C6 and C3M significantly differed among biopsy classes in AAV, with urinary DKK-3 and PRO-C6 levels being highest in the sclerotic class and lowest in the focal class, urinary CD163 levels highest in the crescentic class and urinary C3M levels highest in the focal class. Moreover, the urinary biomarkers were able to discriminate focal biopsy class from the other classes. Urinary DKK-3, EGF, PRO-C6 and C3M levels measured at the time of biopsy were also significantly related to the extent of fibrosis and to the final kidney function at the end of follow-up. CONCLUSIONS: This small pilot study suggests that selected urinary biomarkers of fibrosis and inflammation may reflect changes in the kidney biopsy and be prognostic of kidney outcome in patients with AAV.

Department of Nephrology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czechia

Department of Pathology Institute for Clinical and Experimental Medicine Prague Czechia

Faculty of Environment Jan Evangelista Purkyně University in Ústí nad Labem Ústí nad Labem Czechia

Institute of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czechia

Nordic Bioscience Herlev Denmark

Zobrazit více v PubMed

Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD. ANCA-associated vasculitis with renal involvement: An outcome analysis. Nephrol Dial Transplant. (2004) 19(6):1403–11. doi: 10.1093/ndt/gfh161 PubMed DOI

Moiseev SV, Novikov PI. Classification, diagnosis and treatment of ANCA-associated vasculitis. World J Rheumatol (2015) 5(1):36–44. doi: 10.5499/wjr.v5.i1.36 DOI

Slot MC, Tervaert JW, Franssen CF, Stegeman CA. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int (2003) 63(2):670–7. doi: 10.1046/j.1523-1755.2003.00769.x PubMed DOI

Moiseev S, Novikov P, Jayne D, Mukhin N. End-stage renal disease in ANCA-associated vasculitis. Nephrol Dial Transplant. (2017) 32(2):248–53. doi: 10.1093/ndt/gfw046 PubMed DOI

Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, et al. . Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol: JASN (2010) 21(10):1628–36. doi: 10.1681/ASN.2010050477 PubMed DOI

Zewinger S, Rauen T, Rudnicki M, Federico G, Wagner M, Triem S, et al. . Dickkopf-3 (DKK3) in urine identifies patients with short-term risk of eGFR loss. J Am Soc Nephrol. (2018) 29(11):2722–33. doi: 10.1681/ASN.2018040405 PubMed DOI PMC

Federico G, Meister M, Mathow D, Heine GH, Moldenhauer G, Popovic ZV, et al. . Tubular dickkopf-3 promotes the development of renal atrophy and fibrosis. JCI Insight (2016) 1(1). doi: 10.1172/jci.insight.84916 PubMed DOI PMC

Fang X, Hu J, Chen Y, Shen W, Ke B. Dickkopf-3: Current knowledge in kidney diseases. Front Physiol (2020) 11:533344. doi: 10.3389/fphys.2020.533344 PubMed DOI PMC

O’Reilly VP, Wong L, Kennedy C, Elliot LA, O'Meachair S, Coughlan AM, et al. . Urinary soluble CD163 in active renal vasculitis. JASN (2016) 27(9):2906–16. doi: 10.1681/ASN.2015050511 PubMed DOI PMC

Aendekerk JP, Timmermans SAMEG, Busch MH, Potjewijd J, Heeringa P, Damoiseaux JGMC, et al. . Urinary soluble CD163 and disease activity in biopsy-proven ANCA-associated glomerulonephritis. Clin J Am Soc Nephrol. (2020) 15(12):1740–8. doi: 10.2215/CJN.07210520 PubMed DOI PMC

Gesualdo L, Di Paolo S, Calabró A, Milani S, Maiorano E, Ranieri E, et al. . Expression of epidermal growth factor and its receptor in normal and diseased human kidney: An immunohistochemical and in situ hybridization study. Kidney Int (1996) 49(3):656–65. doi: 10.1038/ki.1996.94 PubMed DOI

Isaka Y. Epidermal growth factor as a prognostic biomarker in chronic kidney diseases. Ann Transl Med (2016) 4(Suppl 1):S62. doi: 10.21037/atm.2016.10.64 PubMed DOI PMC

Bulanov N, Chebotareva NV, Novikov PI, Moiseev SV. Role of tubulointerstitial injury in ANCA-associated vasculitis is underestimated. Ann Rheum Dis (2019) 78(10):e111. doi: 10.1136/annrheumdis-2018-214095 PubMed DOI

Rasmussen DGK, Fenton A, Jesky M, Ferro C, Boor P, Tepel M, et al. . Urinary endotrophin predicts disease progression in patients with chronic kidney disease. Sci Rep (2017) 7(1):17328. doi: 10.1038/s41598-017-17470-3 PubMed DOI PMC

Genovese F, Rasmussen DGK, Karsdal MA, Jesky M, Ferro C, Fenton A, et al. . Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients. Clin Kidney J (2020) 14(2):593–601. doi: 10.1093/ckj/sfz174 PubMed DOI PMC

Rasmussen DGK, Hansen TW, von Scholten BJ, Nielsen SH, Reinhard H, Parving HH, et al. . Higher collagen VI formation is associated with all-cause mortality in patients with type 2 diabetes and microalbuminuria. Diabetes Care (2018) 41(7):1493–500. doi: 10.2337/dc17-2392 PubMed DOI

Fenton A, Jesky MD, Ferro CJ, Sørensen J, Karsdal MA, Cockwell P, et al. . Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease. PloS One (2017) 12(4):e0175200. doi: 10.1371/journal.pone.0175200 PubMed DOI PMC

Sparding N, Genovese F, Rasmussen DGK, Karsdal MA, Neprasova M, Maixnerova D, et al. . Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis. Nephrol Dial Transplant. (2022) 37(6):1099–108. doi: 10.1093/ndt/gfab163 PubMed DOI PMC

Genovese F, Akhgar A, Lim SS, Farris AB, Battle M, Cobb J, et al. . Collagen type III and VI remodeling biomarkers are associated with kidney fibrosis in lupus nephritis. Kidney360 (2021) 2(9):1473–81. doi: 10.34067/KID.0001132021 PubMed DOI PMC

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, et al. . The banff 2015 kidney meeting report: Current challenges in rejection classification and prospects for adopting molecular pathology. Am J Transplant. (2017) 17(1):28–41. doi: 10.1111/ajt.14107 PubMed DOI PMC

Vandeginste BGM, Massart DL, Buydens LMC, De Jong S, Lewi PJ, Smeyers-Verbeke J, et al. . Handbook of chemometrics and qualimetrics, part b. 1st ed. Elsevier; (1998).

Genovese F, Rasmussen D, Nielsen SH, Haas J, Voelker J, Karsdal MA, et al. . A novel urinary biomarker of type VI collagen formation and endotrophin is associated with loss of kidney function in patients with diabetic nephropathy. Nephrol Dialysis Transplant (2017) 32(suppl_3):iii8. doi: 10.1093/ndt/gfx102 DOI

Sun K, Park J, Gupta OT, Holland WL, Auerbach P, Zhang N, et al. . Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction. Nat Commun (2014) 5:3485. doi: 10.1038/ncomms4485 PubMed DOI PMC

Lee C, Kim M, Lee JH, Oh J, Shin HH, Lee SM, et al. . COL6A3-derived endotrophin links reciprocal interactions among hepatic cells in the pathology of chronic liver disease. J Pathol (2019) 247(1):99–109. doi: 10.1002/path.5172 PubMed DOI

Tepel M, Alkaff FF, Kremer D, Bakker SJL, Thaunat O, Nagarajah S, et al. . Pretransplant endotrophin predicts delayed graft function after kidney transplantation. Sci Rep (2022) 12(1):4079. doi: 10.1038/s41598-022-07645-y PubMed DOI PMC

Zhang T, Li H, Vanarsa K, Gidley G, Mok CC, Petri M, et al. . Association of urine sCD163 with proliferative lupus nephritis, fibrinoid necrosis, cellular crescents and intrarenal M2 macrophages. Front Immunol (2020) 11:671. doi: 10.3389/fimmu.2020.00671 PubMed DOI PMC

Wu L, Li XQ, Goyal T, Eddy S, Kretzler M, Ju WJ, et al. . Urinary epidermal growth factor predicts renal prognosis in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis (2018) 77(9):1339–44. doi: 10.1136/annrheumdis-2017-212578 PubMed DOI

Rasmussen DGK, Boesby L, Nielsen SH, Tepel M, Birot S, Karsdal MA, et al. . Collagen turnover profiles in chronic kidney disease. Sci Rep (2019) 9(1):16062. doi: 10.1038/s41598-019-51905-3 PubMed DOI PMC